InMed Pharmaceuticals Inc. (MTRI) stock
MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30
$17.50−2.37 (-11.93%)
Close on Nov 17, 2026Market cap $96.14MP/E –Yield –
InMed Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
InMed Pharmaceuticals's enterprise value was $6.77M on Nov 3, 2026, against -$5.94M a year earlier. Over the last 5 years it ranged from -$9.78M to $6.77M, with a median of -$4.49M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 3, 2026 | $6.77M | – |
| 2025 | Dec 31, 2025 | -$6.64M | – |
| 2024 | Dec 31, 2024 | -$2.44M | – |
| 2023 | Dec 29, 2023 | -$5.42M | – |
| 2022 | Dec 30, 2022 | -$7.56M | – |
| 2021 | Dec 31, 2021 | -$1.86M | -114.7% |
| 2020 | Dec 31, 2020 | $12.63M | – |
See a number that looks wrong?